. . . . . . . . . "Sevoflurane, USP can cause malignant hyperthermia. It should not be used in patients with known sensitivity to sevoflurane, USP or to other halogenated agents nor in patients with known or suspected susceptibility to malignant hyperthermia." . . . . . "RSA" . "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB" . "UZgSBiZY/Y7nCJHlf04/2A8B3Hc4+N5oXDD5AppxPhcjVe2eIthzVsbP7RAYKepZ4ERAdxqHuBN2vSAR+LsHDO3epzif8xyYUXjvls7ihsMlJnELyLBzbCHCTRMdRe4ff2q68scuSAl1Nt4P5P/KcpF36obTsQmKOPCB0YCi4EA=" . . "2021-08-25T14:16:17.389+02:00"^^ . . . . .